Navigation Links
Findings From Largest Industry Assessment of 510(k) Process to be Released on May 24, 2011
Date:5/18/2011

WASHINGTON, May 18, 2011 /PRNewswire/ --

What:  Investigators from Northwestern University will release a new, in-depth analysis of FDA's 510(k) regulatory pathway—through which more than 90% of medical devices receive clearance—and of industry's practices within it. The study is the most comprehensive survey to date about the 510(k) process.

FDA's Center for Devices and Radiological Health (CDRH) is currently weighing regulatory revisions that support innovation; bring important, safe, and effective technologies to patients quickly; and keep jobs in the United States. The agency has also commissioned the Institute of Medicine (IOM) to produce an independent review panel report, which will be released this summer.

The Northwestern findings—based on survey responses from more than 350 medtech product designers and developers, entrepreneurs, academic physician inventors, and regulatory affairs professionals—are expected to help identify key opportunities for improving FDA's product review process.

The survey is part of "A Comprehensive Analysis of the FDA 510(k) Process: Industry Practice and the Implications for Reform," a study funded by the Institute for Health Technology Studies (InHealth), a nonprofit foundation that supports research and analysis into the role of medical technology in advancing healthcare and patient quality of life.

Who:  Survey findings will be presented by investigators John H. Linehan, PhD, professor of biomedical engineering at Northwestern University, and Jan B. Pietzsch, PhD, president and CEO of Wing Tech Inc., a technology consultancy, and a consulting associate professor in Stanford University's Department of Management Science and Engineering, and the Biodesign Program.

Robert J. Rubin, MD, clinical professor of medicine at Georgetown University and chair of InHealth's Research Council, will moderate a respondents' panel comprising Susan Alpert, MD, PhD, recently retired senior vice president and chief regulatory officer at Medtronic; Peter Barton Hutt, senior counsel at Covington & Burling LLP, author of the Medical Device Amendments of 1976; and Philip J. Phillips, president of Phillips Consulting Group LLC and former deputy director for science and regulatory policy in the Office of Device Evaluation at FDA's Center for Devices and Radiological Health. Senior leadership from FDA has been invited to participate.

Where:  Zenger Room, The National Press Club, 529 14th Street NW, Washington, DC

The news conference will be broadcast live via the web at: www.inhealth.org/510ksurveyWhen:  Tuesday, May 24, 8:30 a.m. to 10:30 a.m. Contact:Robyn Stein, gabbegroup, (212) 220-4444, robyn.stein@gabbe.com Caitlin Hool, gabbegroup, (212) 220-4444, caitlin.hool@gabbe.com   For more information about the survey, visit www.510k.net

About InHealth (www.inhealth.org)

The Institute for Health Technology Studies is a nonprofit research and educational organization supporting independent analyses of the social and economic effects of diagnostic and therapeutic medical devices.  


'/>"/>
SOURCE The Institute for Health Technology Studies (InHealth)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Researchers Present Key Findings Comparing PEM to MRI for Identification of Contralateral Breast Cancer at the National Consortium of Breast Centers (NCBC) Conference
2. Positive Findings From Excellagen Matrix Clinical Study Published in Peer-Reviewed Journal Wound Repair and Regeneration
3. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
4. Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium
5. New York Robotic Surgery Expert Dr. David Samadi, MD Discusses New Findings that Hormone Therapy May Increase Risk of Developing Colorectal Cancer
6. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
7. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
8. Ground Breaking Findings on Understanding Cancer Published in the Current Issue of Science
9. Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes
10. Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
11. New Study Findings Could Help Millions Who Suffer From Dry Mouth: Over-The-Counter Muco-Adhesive Patch Outperforms Leading Oral Rinse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017  AllianceRx Walgreens Prime, the combined central ... and pharmacy benefit manager Prime Therapeutics LLC (Prime), today ... included the unveiling of new signage at its headquarters ... as at a few other company-owned facilities across the ... patients, some of whom will begin to see the ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
Breaking Medicine News(10 mins):